The Narrow-Spectrum HDAC Inhibitor Entinostat Enhances NKG2D Expression Without NK Cell Toxicity, Leading to Enhanced Recognition of Cancer Cells

Overview of attention for article published in Pharmaceutical Research, November 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 1 news outlet

patent: 3 patents

Citations

dimensions_citation: 89 Dimensions

Readers on

mendeley: 85 Mendeley

Summary News Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

HDAC inhibitors for use with NK cell based therapies

Grant GB-2567362-B

United Kingdom

Methods of using IL-21 for adoptive immunotherapy and identification of tumor antigens

Grant US-11306289-B2

United States of America

EXPANSION CULTURE METHOD FOR HUMAN-DERIVED NATURAL KILLER CELLS BY USING HDAC INHIBITOR

Application WO-2019221463-A1

World Intellectual Property Organisation (WIPO)